Aurobindo Pharma receives USFDA Approval for Bivalirudin Injection
Aurobindo Pharma receives USFDA Approval for Bivalirudin Injection

Aurobindo Pharma receives USFDA Approval for Bivalirudin Injection

Shohini Nath Article rating: 5.0

Aurobindo Pharma has received the final approval from the US Food and Drug Administration for Bivalirudin Injection indicated for the use as an anticoagulant in patients. The product will be launched in September 2018. With respect to the news, the shares of Aurobindo soared 2 per cent.

 

Ten stocks close to their 52-week high
Ten stocks close to their 52-week high

Ten stocks close to their 52-week high

Shital Jibhe Article rating: 5.0

The markets on July 30, 2018 opened gap up. BSE Sensex is trading at 37,407.49, up by 70.64 points and the Nifty is trading at 11,290.45, up by 12.10 points.

Wockhardt sets-up facility in Middle East, surges by 3.5 per cent
Wockhardt sets-up facility in Middle East, surges by 3.5 per cent

Wockhardt sets-up facility in Middle East, surges by 3.5 per cent

Apurva Joshi Article rating: 5.0

Wockhardt Limited has set-up its first facility in the Middle East for manufacturing of NCEs (New Chemical Entities). It will cater to the global markets through its Dubai arm of its subsidiary Wockhardt Bio AG.

Units of Morepen Labs receives approval for 2 API drugs
Units of Morepen Labs receives approval for 2 API drugs

Units of Morepen Labs receives approval for 2 API drugs

Gayathri Udyawar Article rating: 5.0

The USFDA has accorded twin approvals to the company's bulk drug facilities in Baddi and Masulkhana, in Himachal Pradesh for export to the US market. The stock spiked up by more than 10 per cent on Monday.

Gati shines on talks of acquisition by TVS Logistics
Gati shines on talks of acquisition by TVS Logistics

Gati shines on talks of acquisition by TVS Logistics

Amir Shaikh Article rating: 1.7

Hyderabad-based logistic service provider, Gati Limited surged almost 30 per cent in three trading session amidst news that TVS Logistics is likely to acquire a controlling stake in the company.

Cerebra gains on commencement of second factory in Karnataka
Cerebra gains on commencement of second factory in Karnataka

Cerebra gains on commencement of second factory in Karnataka

Shohini Nath Article rating: 5.0

Cerebra Integrated Technologies announced that the company has commenced construction of their second factory building that will be fully-automated, pollution-free, E-waste recycling facility to handle specifically white goods. Reacting to the announcement, the share price of the company has gone up by over 4 per cent.

 

Confidence Petroleum gains 4 per cent on order win from BPCL
Confidence Petroleum gains 4 per cent on order win from BPCL

Confidence Petroleum gains 4 per cent on order win from BPCL

Nidhi Jani Article rating: 5.0

Confidence Petroleum India has secured the orders for supply of 9.01 LAC LPG cylinders of capacity 14.2 kg amounting to Rs. 139.6 crore from Bharat Petroleum Corporation Limited (BPCL), informed the company on Monday.

Rising rates a positive for FMPs
Rising rates a positive for FMPs

Rising rates a positive for FMPs

Nikhil Desai Article rating: 5.0

With the rising interest rates FMPs form a good investment option. These investment options are able to deliver good returns in comparison to the traditional saving instruments. Let's explore fixed maturity plans (FMP).

RSS
First28712872287328742876287828792880Last

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR